Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine A Pratilas

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
Experimental Neurology|September 2, 2017
The promise of signal transduction in genetically driven sarcomas of the nerveAeRang Kim, Christine A Pratilas
Reviews on Recent Clinical Trials|May 14, 2008
Therapeutic strategies for targeting BRAF in human cancerChristine A Pratilas, David B Solit
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2010
Targeting the mitogen-activated protein kinase pathway: physiological feedback and drug responseChristine A Pratilas, David B Solit
Current Topics in Microbiology and Immunology|August 6, 2011
Targeting oncogenic BRAF in human cancerChristine A Pratilas, Feng Xing, David B Solit
Genes|July 1, 2020
From Genes to -Omics: The Evolving Molecular Landscape of Malignant Peripheral Nerve Sheath TumorKathryn M Lemberg, Jiawan Wang, Christine A Pratilas
Cancer Research|November 18, 2020
Activation of Receptor Tyrosine Kinases Mediates Acquired Resistance to MEK Inhibition in Malignant Peripheral Nerve Sheath TumorsJiawan Wang, Kai Pollard, Ana Calizo, et al.
Cancers|August 31, 2019
BRAF Mutations and the Utility of RAF and MEK Inhibitors in Primary Brain TumorsKarisa C Schreck, Stuart A Grossman, Christine A Pratilas
Genes|September 5, 2020
Special Issue: "Genomics and Models of Nerve Sheath Tumors"Angela C Hirbe, Rebecca D Dodd, Christine A Pratilas
Adolescent Health, Medicine and Therapeutics|April 15, 2017
Targeted therapy for soft tissue sarcomas in adolescents and young adultsDiana A Steppan, Christine A Pratilas, David M Loeb
Neuro-Oncology Advances|November 25, 2020
Combination MEK and mTOR inhibitor therapy is active in models of glioblastomaKarisa C Schreck, Amy N Allen, Jiawan Wang, et al.
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
Experimental Neurology|September 2, 2017
The promise of signal transduction in genetically driven sarcomas of the nerveAeRang Kim, Christine A Pratilas
Reviews on Recent Clinical Trials|May 14, 2008
Therapeutic strategies for targeting BRAF in human cancerChristine A Pratilas, David B Solit
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2010
Targeting the mitogen-activated protein kinase pathway: physiological feedback and drug responseChristine A Pratilas, David B Solit
Current Topics in Microbiology and Immunology|August 6, 2011
Targeting oncogenic BRAF in human cancerChristine A Pratilas, Feng Xing, David B Solit
Genes|July 1, 2020
From Genes to -Omics: The Evolving Molecular Landscape of Malignant Peripheral Nerve Sheath TumorKathryn M Lemberg, Jiawan Wang, Christine A Pratilas
Cancer Research|November 18, 2020
Activation of Receptor Tyrosine Kinases Mediates Acquired Resistance to MEK Inhibition in Malignant Peripheral Nerve Sheath TumorsJiawan Wang, Kai Pollard, Ana Calizo, et al.
Cancers|August 31, 2019
BRAF Mutations and the Utility of RAF and MEK Inhibitors in Primary Brain TumorsKarisa C Schreck, Stuart A Grossman, Christine A Pratilas
Genes|September 5, 2020
Special Issue: "Genomics and Models of Nerve Sheath Tumors"Angela C Hirbe, Rebecca D Dodd, Christine A Pratilas
Adolescent Health, Medicine and Therapeutics|April 15, 2017
Targeted therapy for soft tissue sarcomas in adolescents and young adultsDiana A Steppan, Christine A Pratilas, David M Loeb
Neuro-Oncology Advances|November 25, 2020
Combination MEK and mTOR inhibitor therapy is active in models of glioblastomaKarisa C Schreck, Amy N Allen, Jiawan Wang, et al.
Pageof 11